Drug Type Gene therapy |
Synonyms GEN 1013, GEN1013 |
Target |
Mechanism IL-12 inhibitors(Interleukin-12 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 20 May 2024 |